Read More 1 minute read Analyst Ratings News Price Target Reiteration Rosenblatt Reiterates Neutral on Luminar Technologies, Maintains $8 Price Target By Benzinga Newsdesk March 1, 8:25 AM Rosenblatt analyst Kevin Cassidy reiterates Luminar Technologies (NASDAQ:LAZR) with a Neutral and maintains $8 price target. LAZR
Read More 1 minute read Analyst Ratings News Price Target Reiteration Rosenblatt Reiterates Buy on Arteris, Maintains $21 Price Target By Benzinga Newsdesk March 1, 8:23 AM Rosenblatt analyst Hans Mosesmann reiterates Arteris (NASDAQ:AIP) with a Buy and maintains $21 price target. AIP
Read More 1 minute read Analyst Ratings News Price Target Reiteration EF Hutton Reiterates Buy on Allogene Therapeutics, Maintains $15 Price Target By Benzinga Newsdesk March 1, 8:13 AM EF Hutton analyst Tony Butler reiterates Allogene Therapeutics (NASDAQ:ALLO) with a Buy and maintains $15 price target. ALLO
Read More 1 minute read Analyst Ratings News Price Target Reiteration EF Hutton Reiterates Buy on UMH Properties, Maintains $21 Price Target By Benzinga Newsdesk March 1, 8:03 AM EF Hutton analyst Gaurav Mehta reiterates UMH Properties (NYSE:UMH) with a Buy and maintains $21 price target. UMH
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Applied Mat, Maintains $135 Price Target By Benzinga Newsdesk March 1, 7:57 AM Needham analyst Quinn Bolton reiterates Applied Mat (NASDAQ:AMAT) with a Buy and maintains $135 price target. AMAT
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Nerdy, Maintains $5 Price Target By Benzinga Newsdesk March 1, 7:53 AM Needham analyst Ryan MacDonald reiterates Nerdy (NYSE:NRDY) with a Buy and maintains $5 price target. NRDY
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Avidity Biosciences, Maintains $35 Price Target By Benzinga Newsdesk March 1, 7:51 AM Needham analyst Joseph Stringer reiterates Avidity Biosciences (NASDAQ:RNA) with a Buy and maintains $35 price target. RNA
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Shutterstock, Maintains $90 Price Target By Benzinga Newsdesk March 1, 7:50 AM Needham analyst Bernie McTernan reiterates Shutterstock (NYSE:SSTK) with a Buy and maintains $90 price target. SSTK
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Duolingo, Maintains $115 Price Target By Benzinga Newsdesk March 1, 7:41 AM Needham analyst Ryan MacDonald reiterates Duolingo (NASDAQ:DUOL) with a Buy and maintains $115 price target. DUOL
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Celldex Therapeutics, Maintains $73 Price Target By Benzinga Newsdesk March 1, 7:19 AM HC Wainwright & Co. analyst Joseph Pantginis reiterates Celldex Therapeutics (NASDAQ:CLDX) with a Buy and maintains $73 price target. CLDX